Department of Neurology, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, 260, Gonghang-daero, Gangseo-gu, Seoul, 07804, Republic of Korea.
Sci Rep. 2024 Oct 25;14(1):25376. doi: 10.1038/s41598-024-75384-3.
Proteinuria is an important risk factor for cardiovascular disease (CVD) and acts as a surrogate marker of renal damage. This study aimed to determine the association between changes in proteinuria and the occurrence of CVD. In our study, 1,708,712 participants who consecutively underwent national health examinations from 2003-2004 (first period) to 2005-2006 (second period) were included. They were classified into four groups based on the presence of proteinuria at the two consecutive health examinations: (1) normal (0 → 0), (2) proteinuria-improved (participants who had improved proteinuria (+ 1 → 0, + 2 → ≤ +1 [0 or + 1], ≥ +3 → ≤ +2 [0, + 1 or + 2]), (3) proteinuria-progressed (0 → ≥ +1, + 1 → ≥ +2, + 2 → ≥ +3), and (4) proteinuria-persistent (+ 1 → +1, + 2 → +2, ≥ +3 → ≥ +3). We used a multivariate Cox proportional hazards model to assess the occurrence of CVD according to changes of presence and severity of proteinuria. During a median of 14.2 years of follow-up, 143,041 participants (event rate, 8.37%) with composite CVD were observed. Compared with the normal group, the risk of incident risk of CVD was increased according to the severity of proteinuria in each of the persistent, progressed, and improved groups (p for trend < 0.001). In a pairwise comparison, the risk of composite CVD in the improved (hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.27-1.37), progressed (HR: 1.49, 95% CI: 1.44-1.54), and persistent groups (HR: 1.78, 95% CI: 1.64-1.94) were higher than that of the normal group. Furthermore, the improved group had a relatively lower risk of composite CVD compared to the persistent group (HR: 0.75, 95% CI: 0.69-0.83, p < 0.001). The incidence risk of composite CVD was associated with changes of presence and severity of proteinuria. Persistent proteinuria may be associated with increased risk of CVD, even compared with improved or progressed proteinuria status.
蛋白尿是心血管疾病(CVD)的一个重要危险因素,可作为肾脏损害的替代标志物。本研究旨在确定蛋白尿变化与 CVD 发生之间的关联。
在这项研究中,纳入了 2003-2004 年(第一期)至 2005-2006 年(第二期)连续接受国家健康检查的 1708712 名参与者。根据两次连续健康检查中蛋白尿的存在情况,他们被分为四组:(1)正常(0→0);(2)蛋白尿改善(蛋白尿改善的参与者(+1→0,+2→≤+1[0 或+1],≥+3→≤+2[0、+1 或+2]);(3)蛋白尿进展(0→≥+1,+1→≥+2,+2→≥+3);(4)蛋白尿持续(+1→+1,+2→+2,≥+3→≥+3)。
我们使用多变量 Cox 比例风险模型来评估根据蛋白尿存在和严重程度变化发生 CVD 的情况。在中位数为 14.2 年的随访期间,观察到 143041 名(事件发生率 8.37%)复合 CVD 患者。与正常组相比,在持续、进展和改善组中,蛋白尿严重程度每增加一级,发生 CVD 的风险均增加(趋势 p<0.001)。在两两比较中,改善组(风险比 [HR]:1.32,95%置信区间 [CI]:1.27-1.37)、进展组(HR:1.49,95% CI:1.44-1.54)和持续组(HR:1.78,95% CI:1.64-1.94)发生复合 CVD 的风险均高于正常组。此外,与持续组相比,改善组发生复合 CVD 的风险相对较低(HR:0.75,95% CI:0.69-0.83,p<0.001)。
复合 CVD 的发病风险与蛋白尿存在和严重程度的变化相关。持续性蛋白尿可能与 CVD 风险增加有关,甚至与改善或进展性蛋白尿状态相比也是如此。